You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
|
|---|---|
| Published in |
Lancet Neurology, December 2014
|
| DOI | 10.1016/s1474-4422(14)70288-1 |
| Pubmed ID | |
| Authors |
Werner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, Gregor K Wenning, Sid Gilman, Phillip A Low, Nir Giladi, Paolo Barone, Cristina Sampaio, Eli Eyal, Olivier Rascol, for the Rasagiline-for-MSA investigators |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 24% |
| United Kingdom | 4 | 19% |
| Spain | 1 | 5% |
| Egypt | 1 | 5% |
| Canada | 1 | 5% |
| Chile | 1 | 5% |
| Argentina | 1 | 5% |
| Unknown | 7 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 71% |
| Practitioners (doctors, other healthcare professionals) | 2 | 10% |
| Scientists | 2 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Austria | 1 | <1% |
| India | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 138 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 16% |
| Student > Ph. D. Student | 19 | 13% |
| Student > Master | 18 | 13% |
| Other | 16 | 11% |
| Professor > Associate Professor | 11 | 8% |
| Other | 28 | 20% |
| Unknown | 28 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 31% |
| Neuroscience | 16 | 11% |
| Psychology | 13 | 9% |
| Nursing and Health Professions | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Other | 19 | 13% |
| Unknown | 38 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2015.
All research outputs
#1,267,139
of 25,371,288 outputs
Outputs from Lancet Neurology
#822
of 4,011 outputs
Outputs of similar age
#16,517
of 368,071 outputs
Outputs of similar age from Lancet Neurology
#9
of 60 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,011 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,071 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.